Panjon Ltd.
Snapshot View

16.65 +0.15 ▲0.9%

07 February 2023, 04:01:00 PM
Volume: 3,032

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.panjon.in
Market Cap 25.81 Cr.
Enterprise Value(EV) 26.46 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -2.59 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.80 Trailing Twelve Months Ending 2022-09
Book Value / Share 8.23 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.02 Calculated using Price: 16.65
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.55 Cr. 15,498,700 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.91%
1 Week
+0.30%
1 Month
-9.02%
3 Month
+7.42%
6 Month
+26.71%
1 Year
-44.13%
2 Year
5 Year
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -0.98 -17.68 2.23 0.71 0.74 0.84 -0.19 0.57 -28.17
Return on Capital Employed (%) 0.43 -22.21 0.94 1.75 2.03 2.59 1.84 1.60 -24.99
Return on Assets (%) -0.68 -15.33 2.11 0.68 0.70 0.78 -0.18 0.52 -25.77

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 24 16 16 17 17 17 17 17 13 13
Non Curr. Liab. 2 1 0 0 0 0 1 0 0 0
Curr. Liab. 1 1 0 1 1 1 1 1 1 1
Minority Int.
Equity & Liab. 27 17 17 17 18 18 19 19 14 14
Non Curr. Assets 7 2 2 2 10 9 7 7 5 2
Curr. Assets 19 15 15 15 8 9 11 12 9 12
Misc. Exp. not W/O 2
Total Assets 27 17 17 17 18 18 19 19 14 14

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 19 19 12 14 20 26 26 15 8 8
Other Income 0 0 0 1 0 0 0 0 0 0
Total Income 19 20 13 15 20 26 27 15 9 9
Total Expenditure -19 -23 -12 -14 -20 -26 -26 -14 -12 -12
PBIDT 0 -3 0 0 0 1 1 1 -4 -4
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 1 0 0 0 0 0 0 0
Exceptional Items -2
PAT 0 -3 0 0 0 0 0 0 -4 -4
Adjusted EPS 0 -2 0 0 0 0 0 0 -3 -3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -6 -3 1 0 0 0 0 0 0 2
Cash Fr. Inv. 0 0 5 0 0 0 0 -1 0 0
Cash Fr. Finan. 6 3 -5 0 0 0 0 0 0 -1
Net Change 0 0 0 0 0 0 0 0 0 1
Cash & Cash Eqvt 0 0 1 0 0 0 1 0 0 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 52.03 52.03 52.03 52.03 52.03 52.03 52.03 52.03 52.03
Public 47.97 47.97 47.97 47.97 47.97 47.97 47.97 47.97 47.97
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 21 Jan 2023
Board Meeting Intimation for The Quarter Ended December 31 2022 Is Scheduled To Be Held On Saturday February 11 2023 At 11:00 A.M.
PANJON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2023 inter alia to consider and approve In pursuant to Regulation 29 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that Board Meeting of the Company for the Quarter ended December 31 2022 is scheduled to be held on Saturday February 11 2023 at 11:00 A.M. at the registered office of the Company the Board has to consider and approve:1) The Un-audited Standalone Financial Results of the Company for the Nine months and Quarter ended December 31 2022 along with Limited Review Report thereon; 2) Appointment & Resignation of Company Secretary of the company ;3) Any other item if any.
Sat, 14 Jan 2023
Disclosure Under Regulation 30 Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.
In pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 the Company wishes to inform that Company Secretary of Company Miss Sonam Asati (Membership no : 67268) has resigned from the post of Company Secretary w.e.f 26.11.2022.
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Please find enclosed herewith a certificate received from Skyline Financial Services Pvt Ltd Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022.

Technical Scans View Details >>

Tue, 07 Feb 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Decrease in 1 Year High Decrease in 1 Year
William %R Trending Up William %R Trending Up

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,005.65 -1.7%
Cipla Ltd. 83,256.90 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,441.90 +2.1%
Divi's Laboratories Ltd. 72,982.62 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. 62,135.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. 51,898.92 1,533.45 -0.4%
Zydus Lifesciences Ltd. 48,525.07 479.40 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 31.56 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 479.40 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 3.67 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 479.40 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.40 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.40 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.40 +2.0%

FAQ's On Panjon Ltd.

What is Panjon share price?

Can I buy Panjon shares now?

What is the Market Cap of Panjon?

What are the key metrics to analyse Panjon?

What is the 52 Week High and Low of Panjon?

What is the trend of Panjon share price?